课题基金 / 基金详情

The mechanism of phiC31 integrase; a tool for gene therapy and genome manipulation

The mechanism of phiC31 integrase; a tool for gene therapy and genome manipulation
phiC31整合酶的机制;
批准号:
BB/D007836/1
负责人:
Margaret Smith
金额:
$58.67万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --

项目摘要

项目成果

Margaret Smith的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is really difficult to cure people with genetic diseases, such as muscular dystrophy, where they have the wrong gene. The best cure would be to give them the right gene, one that works well. Ideally this treatment would need to be given only once in their lifetime because genes, when they are part of the chromosome, are passed faithfully from one cell to the next and so the cure would perpetuate. Although this sounds simple, in practice its very hard. This project concerns a possible way of getting the right gene into a sick person's chromosome. Some viruses, mostly those that infect bacteria, have a way of getting their own genes into the chromosome of their hosts. This process involves proteins, called integrases, because they integrate two pieces of DNA into one. Most integrases use a particular site in the host chromosome preferentially over all others and the virus DNA goes into that site. There is also a preferred site in the virus DNA. In order to introduce correct genes into people as a cure for disease, we need to engineer the integrase so that it can find its preferred site in that person's chromosome. Consequently this project is about understanding how these integrases work so that we can alter them rationally. We would like to know, for instance, which part of the integrase is responsible for recognising its preferred integration site? Another feature of integrase is that it is irreversible in the absence of any other virus proteins. This means that once the correct gene is inserted it is there forever, hence the need for only one treatment. We think that integrase can detect the presence of its preferred sites very early on in the reaction pathway, the stage that brings the two preferred sites together. There is a kind of lock and key interaction within integrase that activates the rest of the pathway to complete integration. Without the right lock and key interaction the pathway is blocked. Almost all of this project will be done with integrases that we have altered in some way by mutation. By studying how the properties of the integrases change we can understand how the proteins work. Some of the work will be done in collaboration with scientists who can determine the 3-dimensional (3-D) structure of proteins. With them we aim to obtain a 3-D structure of integrase with its preferred sites for integration. A third part of this work addresses a process called excision, the opposite of integration and is where virus DNA is excised from the host chromosome. Although integrase by itself is not reversible and only integrates DNA, the virus that encodes it must be able to excise its DNA from its host chromosome. We intend to search for a protein that interacts with integrase to change its properties to do excision. This will help us to understand more about the whole integration/excision process and add to our ability to design better ways to deliver genes to sick people.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Sequences in attB that affect the ability of phiC31 integrase to synapse and to activate DNA cleavage.
ATTB中影响PHIC31积分酶突触和激活DNA裂解的能力的序列。
DOI: 10.1093/nar/gkm206
发表时间: 2007
期刊: NUCLEIC ACIDS RESEARCH
影响因子: 14.9
作者: [Gupta, Milind, Till, Rob, Smith, Margaret C M]
通讯作者: Smith, Margaret C M
DOI: 10.1093/nar/gkn269
发表时间: 2008-07
期刊: NUCLEIC ACIDS RESEARCH
影响因子: 14.9
作者: [Rowley, Paul A., Smith, Matthew C. A., Younger, Ellen, Smith, Margaret C. M.]
通讯作者: Smith, Margaret C. M.
DOI: 10.1093/nar/gkp485
发表时间: 2009-08
期刊: Nucleic acids research
影响因子: 14.9
作者: [McEwan AR, Rowley PA, Smith MC]
通讯作者: Smith MC
SBIR Phase I: A language learning app based on sound and mouth movements
  • 批准号:
    2323040
  • 项目类别:
    Standard Grant
  • 资助金额:
    $27.47万
  • 财政年份:
    2023
  • 负责人:
    Margaret Smith
  • 依托单位:
TARGeTED: Tackling Antimicrobial Resistance through Goal-orientated Thinking in the EPS Disciplines
  • 批准号:
    EP/M027538/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $51.34万
  • 财政年份:
    2015
  • 负责人:
    Margaret Smith
  • 依托单位:
Novel industrial bioprocesses for production of key valuable steroid precursors from phytosterols
  • 批准号:
    BB/L003619/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $39.79万
  • 财政年份:
    2013
  • 负责人:
    Margaret Smith
  • 依托单位:
Overcoming antibiotic resistance by studying antibiotic hypersensitivity
  • 批准号:
    BB/J016691/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $69.6万
  • 财政年份:
    2012
  • 负责人:
    Margaret Smith
  • 依托单位:
国内基金
海外基金
噬菌体phiC31整合酶在牛基因组中介导基因定点整合的分子机制研究
  • 批准号:
    31301009
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2013
  • 负责人:
    曲立娟
  • 依托单位:
联合应用phiC31整合酶与微环载体对β654地中海贫血小鼠进行基因治疗
  • 批准号:
    81300449
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    周在威
  • 依托单位:
基于ZFN/phiC31系统的新型基因打靶技术的建立(果蝇)
  • 批准号:
    31171278
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    高冠军
  • 依托单位: